Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Condition:   Type2 Diabetes Interventions:   Drug: Evogliptin 5mg;   Drug: Evogliptin Placebo;   Drug: Dapagliflozin 10mg;   Drug: Metformin ≥ 1000mg Sponsor:   Dong-A ST Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials